effect of Sovodak in patients with hepatitis C and HIV-1

Phase 2

• Conditions: Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.; Acute hepatitis C; Human immunodeficiency virus [HIV] disease

• Registration Number: IRCT20180924041107N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

patients infected with HIV virus who get anti retroviral treatments and simultaneously infected with hepatitis C virus.

Exclusion Criteria

patients who previously received treatments for hepatitis C
patients with kidney disease
patients with advanced cirrhosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Viral load. Timepoint: before treatments and 3 months after treatments. Method of measurement: RTPCR.